Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Mar 23, 2007 at 4:04 AM EDT

Thursday’s Top Biotech & Medical Stocks

From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotechnology OSIRIS THERAPEUTICS [OSIR] +15.40% REXAHN PHARMACEUTICL [RXHN.OB] +12.90% ADVENTRX PHARMACTL [ANX] +10.05%…

Douglas A. McIntyre | Mar 22, 2007 at 3:21 PM EDT

Dendreon’s Stock Activity

Dendreon (DNDN-NASDAQ) started making a mystery move at the end of the day, but you have to look at its…

Douglas A. McIntyre | Mar 22, 2007 at 3:07 AM EDT

Wednesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com Biotechnology OSIRIS THERAPEUTICS [OSIR] +12.53% EMERGENT BIOSOLUTION [EBS] +9.25% ZIOPHARM ONCOLOGY IN [ZIOP] +8.91% NANOGEN INC…

Douglas A. McIntyre | Mar 21, 2007 at 5:28 PM EDT

Cramer’s Play on Diabetes

On tonight’s MAD MONEY on CNBC, Jim Cramer said the action of the Defensive Stocks makes you need to watch…

Douglas A. McIntyre | Mar 21, 2007 at 1:47 PM EDT

Conflicts of Interest Statement for FDA Advisory Committees

Did you ever think the FDA or other industry-government regulatory and advisory boards were free from a conflict of interest? …

Douglas A. McIntyre | Mar 21, 2007 at 3:02 AM EDT

Tuesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com Biotechnology GENVEC INC [GNVC] +11.51% REXAHN PHARMACEUTICL [RXHN.OB] +10.71% 3SBIO INC [SSRX] +9.64% TERCICA INC [TRCA]…

Douglas A. McIntyre | Mar 20, 2007 at 8:20 AM EDT

As Alzheimer’s Dementia Increases So Could Nursing Home Stocks

The number of people with Alzheimer’s disease rises above five million, one of the questions that come up is who…

Douglas A. McIntyre | Mar 20, 2007 at 4:21 AM EDT

Coated Stent Sales Stay In Reverse

Coated stents cost more than un-coated ones. Putting the drugs onto the coated stents must add expense. But, that means…

Douglas A. McIntyre | Mar 20, 2007 at 3:00 AM EDT

Monday’s Top Biotech & Medical Stocks

Biotechnology ACADIA PHARMACEUTICA [ACAD] +103.44% NEURALSTEM INC [NRLS.OB] +10.51% CYTRX CP [CYTR] +10.19% ACORDA THERAPEUTICS [ACOR] +8.55% REXAHN PHARMACEUTICL [RXHN.OB]…

Douglas A. McIntyre | Mar 19, 2007 at 1:35 PM EDT

Triad (TRI): How Much Higher of a Bid Is There?

Is this the LAST buyout offer for Triad (TRI)? Based on all of the old data, this is now toward…

Douglas A. McIntyre | Mar 19, 2007 at 7:52 AM EDT

Biotech Implosion: AtheroGenics (AGIX)

AtheroGenics Inc. (AGIX-NASDAQ) is the latest biotech implosion this morning. It went from bad to worse as its late-stage clinical…

Douglas A. McIntyre | Mar 19, 2007 at 6:35 AM EDT

Cramer’s Biotech Zombie Looking Up

On Friday’s MAD MONEY on CNBC, Jim Cramer discussed Nastech Pharma (NSTK). This is one of the biotech zombies that…

Douglas A. McIntyre | Mar 19, 2007 at 3:03 AM EDT

High Cost of New Cancer Drugs Force Government Intervention

From BioHealth Investor by H.S. AyoubBioHealth Investor.com Morgan Stanley analyst Steven Harr has been warning Genentech and other drug firms…

Douglas A. McIntyre | Mar 16, 2007 at 8:01 AM EDT

Hollis Eden: What Else They Have Under the Hood

Hollis Eden (HEPH), a micro-cap drug development company, is up roughly 7% at $2.68 pre-market after the company announced it…

Douglas A. McIntyre | Mar 16, 2007 at 3:05 AM EDT

Thursday’s Top Biotech & Medical Stocks

Biotechnology MICROMET INC [MITI] +16.00% NEOSE TECH INC [NTEC] +13.14% TRUBION PHARMACEUTIC [TRBN] +8.91% CYPRESS BIOSCIENCE [CYPB] +8.80% OBAGI MEDICAL…

1 … 376 377 378 379 380 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Thursday’s Top Biotech & Medical Stocks

Dendreon’s Stock Activity

Wednesday’s Top Biotech & Medical Stocks

Cramer’s Play on Diabetes

Conflicts of Interest Statement for FDA Advisory Committees

Tuesday’s Top Biotech & Medical Stocks

As Alzheimer’s Dementia Increases So Could Nursing Home Stocks

Coated Stent Sales Stay In Reverse

Monday’s Top Biotech & Medical Stocks

Triad (TRI): How Much Higher of a Bid Is There?

Biotech Implosion: AtheroGenics (AGIX)

Cramer’s Biotech Zombie Looking Up

High Cost of New Cancer Drugs Force Government Intervention

Hollis Eden: What Else They Have Under the Hood

Thursday’s Top Biotech & Medical Stocks

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Health and Healthcare Articles

All Health and Healthcare Articles

Thursday’s Top Biotech & Medical Stocks

Dendreon’s Stock Activity

Wednesday’s Top Biotech & Medical Stocks

Cramer’s Play on Diabetes

Conflicts of Interest Statement for FDA Advisory Committees

Tuesday’s Top Biotech & Medical Stocks

As Alzheimer’s Dementia Increases So Could Nursing Home Stocks

Coated Stent Sales Stay In Reverse

Monday’s Top Biotech & Medical Stocks

Triad (TRI): How Much Higher of a Bid Is There?

Biotech Implosion: AtheroGenics (AGIX)

Cramer’s Biotech Zombie Looking Up

High Cost of New Cancer Drugs Force Government Intervention

Hollis Eden: What Else They Have Under the Hood

Thursday’s Top Biotech & Medical Stocks

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do